CanSino Biologics (SHSE:688185) Interest Expense : ¥-70.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CanSino Biologics's interest expense for the three months ended in Mar. 2024 was ¥ -14.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-70.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CanSino Biologics's Operating Income for the three months ended in Mar. 2024 was ¥ -105.7 Mil. CanSino Biologics's Interest Expense for the three months ended in Mar. 2024 was ¥ -14.7 Mil. CanSino Biologics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CanSino Biologics Interest Expense Historical Data

The historical data trend for CanSino Biologics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Interest Expense Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.09

-0.14

-20.42

-41.34

-64.15

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial													-8.76	-20.51	-16.69	-18.19	-14.67

CanSino Biologics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-70.1 Mil.

CanSino Biologics (SHSE:688185) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CanSino Biologics's Interest Expense for the three months ended in Mar. 2024 was ¥-14.7 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥-105.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥1,162.7 Mil.

CanSino Biologics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

CanSino Biologics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CanSino Biologics (SHSE:688185) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » Interest Expense

Traded in Other Exchanges

CASBF:USA 06185:Hong Kong CJH:Germany

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (SHSE:688185) Headlines

No Headlines